Escalon Medical Corp. — Revenue by Fiscal Year
15 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/ca38e910-fefe-488a-85fc-cd495bc7321a/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $12.0M | 2024-07-01 – 2025-06-30 | evidence 0001628280-25-043095 |
| FY 2024 | $12.0M | 2023-07-01 – 2024-06-30 | evidence 0000862668-24-000022 |
| FY 2023 | $12.2M | 2022-07-01 – 2023-06-30 | evidence 0000862668-23-000022 |
| FY 2022 | $10.7M | 2021-07-01 – 2022-06-30 | evidence 0000862668-22-000023 |
| FY 2021 | $10.5M | 2020-07-01 – 2021-06-30 | evidence 0000862668-21-000013 |
| FY 2020 | $9.4M | 2019-07-01 – 2020-06-30 | evidence 0000862668-21-000013 |
| FY 2019 | $9.6M | 2018-07-01 – 2019-06-30 | evidence 0000862668-20-000008 |
| FY 2018 | $11.4M | 2017-07-01 – 2018-06-30 | evidence 0000862668-19-000010 |
| FY 2017 | $11.2M | 2016-07-01 – 2017-06-30 | evidence 0000862668-17-000014 |
| FY 2016 | $11.6M | 2015-07-01 – 2016-06-30 | evidence 0000862668-16-000043 |
| FY 2015 | $13.1M | 2014-07-01 – 2015-06-30 | evidence 0000862668-15-000011 |
| FY 2014 | $12.4M | 2013-07-01 – 2014-06-30 | evidence 0000862668-14-000007 |
| FY 2013 | $11.5M | 2012-07-01 – 2013-06-30 | evidence 0000862668-13-000011 |
| FY 2012 | $11.5M | 2011-07-01 – 2012-06-30 | evidence 0000862668-13-000011 |
| FY 2011 | $25.6M | 2010-07-01 – 2011-06-30 | evidence 0001445305-12-003000 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Escalon Medical Corp. — all facts · Net Income · Operating Income